UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade
University of California, Davis
University of California, Davis
Providence Health & Services
Stanford University
University of California, Davis
Fred Hutchinson Cancer Center
Stanford University
University of California, San Francisco
Stanford University
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
NYU Langone Health
University of Utah
Alliance for Clinical Trials in Oncology
University of Rochester
National Institutes of Health Clinical Center (CC)